Progress in Gene Therapy to Prevent Retinal Ganglion Cell Loss in Glaucoma and Leber’s Hereditary Optic Neuropathy

<div>GFP expression and colocalization with retinal markers three weeks after intravitreal injection of AAV2-CAG GFP into the mouse eye. TUJ1 = retinal ganglion cells; CALBINDIN = amacrine cells. Image courtesy of Dr. Andrew Osborne.</div>

Neural Plasticity

fig2

Figure 2

Figure 2: Progress in Gene Therapy to Prevent Retinal Ganglion Cell Loss in Glaucoma and Leber’s Hereditary Optic Neuropathy 